These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 7792738

  • 61. [Modified Bethesda, modified Nijmegen and blank assays for coagulation factor VIII inhibitor detection and factors affecting the results].
    Feng HM, Li Q, Xu WS, Chen DM, Zheng L.
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 36(4):592-5. PubMed ID: 27113194
    [Abstract] [Full Text] [Related]

  • 62.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 63. Inhibitor treatment in haemophilias A and B: inhibitor diagnosis.
    DiMichele DM.
    Haemophilia; 2006 Dec; 12 Suppl 6():37-41; discussion 41-2. PubMed ID: 17123392
    [Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67. Factor VIII clotting antigen (VIIICAg) in haemophilia measured by two immunoradiometric assays (IRMA) using different antibodies, and the measurement of inhibitors to procoagulant factor VIII (VIIIC) by IRMA.
    Furlong RA, Peake IR, Bloom AL.
    Br J Haematol; 1981 Aug; 48(4):643-50. PubMed ID: 6791678
    [Abstract] [Full Text] [Related]

  • 68. Inhibitors in young boys with haemophilia.
    Lusher JM.
    Baillieres Best Pract Res Clin Haematol; 2000 Sep; 13(3):457-68. PubMed ID: 11030045
    [Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73. [Lymphocyte T population in hemophilia A and its relation with factor VIII therapy and the presence of HBsAg or anti-F.VIII:C inhibitors].
    Aznar JA, Carbonell F, Jorquera JI, Carmona E, Sánchez-Cuenca JM, Trénor A, de Andrés-Medina R, González-Molina A.
    Sangre (Barc); 1985 Sep; 30(5):821-30. PubMed ID: 3937253
    [No Abstract] [Full Text] [Related]

  • 74. Effect of phospholipid on factor VIII inactivation.
    Barrowcliffe TW, Kemball-Cook G, Gray E.
    Prog Clin Biol Res; 1984 Sep; 150():251-63. PubMed ID: 6431431
    [No Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76. Neoantigens and antibodies to factor VIII.
    Prowse CV, MacGregor IR.
    Blood Rev; 1998 Jun; 12(2):99-105. PubMed ID: 9661798
    [Abstract] [Full Text] [Related]

  • 77. Reactivity of factor VIII inhibitors in a micro ELISA for factor VIII: CAg and in solid phase immunoisolation of VIII: CAg.
    Nordfang O, Ezban M, Dinesen B.
    Thromb Haemost; 1985 Jun 24; 53(3):346-50. PubMed ID: 3931283
    [Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80. Low-titre inhibitors, undetectable by the Nijmegen assay, reduce factor VIII half-life after immune tolerance induction.
    Dardikh M, Albert T, Masereeuw R, Oldenburg J, Novakova I, van Heerde WL, Verbruggen B.
    J Thromb Haemost; 2012 Apr 24; 10(4):706-8. PubMed ID: 22284849
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.